Abstract-Effects of repeated administration of scopolamine at 0.5, 2.0 and 8.0 mg/kg s.c. on ambulatory activity in mice were investigated. The drug was administered 5 times at intervals of daily, 3-4 days and weekly. The ambulation-increasing effect of scopola mine progressively decreased when the mice were put into a tilting-type round activity cage of 25 cm in diameter and 1 3 cm in height during the presence of the acute drug effect. The tolerance, once produced, was maintained even 1 month after the withdrawal. In contrast, development of tolerance to the ambulation-increasing effect of scopolamine could not be found when the mice were put into a glass jar with a 5.5 cm diameter, in which the ambulation was perfectly restricted, after each drug administration. The present results suggest that the tolerance to the ambulation-increasing effect of scopola mine induced by repeated administration may be elicited by an interaction between the experimental situation and the drug effect.
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It has been well known that behavioral effects of psychotropic drugs sometimes change after repeated administration.
Toler ance appears to behavioral effects on differ ential reinforcement of low rate (DRL) and fixed ratio (FR) responses of food reinforce ment in rats after repeated administration of d-amphetamine (1) (2) (3) (4) . In contrast, reverse tolerance (an increase in the susceptibility to the drug effects) appears to facilitating effects of d-amphetamine and methamphe tamine on the conditioned avoidance response in rats (4, 5) and on the spon taneous motor activity in mice and rats (6 11). Moreover, Schuster and Zimmerman (2), Schuster et al. (3), Tilson and Rech (4), Kuribara (5), Alam (6) , and Hirabayashi and Alam (9) demonstrated that both the tolerance and the reverse tolerance to the behavioral effects of amphetamines were found only in the animals which were repeatedly exposed to the corresponding experimental situation during the presence of the acute drug effects. The behavioral effects of scopolamine, a muscarinic-cholinergic blocker, in mouse and rat resemble those of amphetamines (12 22). However, there have been relatively few reports on the behavioral effects of scopol amine after repeated administration. Rosic et al. (19) demonstrated that daily adminis tration of scopolamine to rats in their home cages for 21 days induced a tolerance to the ambulation-increasing effect, but not to the facilitating effect on acquisition of an active avoidance response. They then considered that the task-dependent development of tolerance to scopolamine was related to the separate effects of the drug on different neurological subsystems. However, as demonstrated after repeated administration of amphetamines (2-6, 9), it is expected that the changes in the behavioral effects of scopolamine are also affected by the experi mental situations to which the animals are exposed during the presence of the acute drug effect.
The purpose of this experiment was to investigate the relationship between experi mental situations, in which the mice were freely movable or restricted, and change in the ambulation-increasing effect of scopola mine after repeated administration in mice.
Materials and Methods
Animals: The experimental animals used were 320 male mice of the dd strain, which were provided by the Institute of Experimental Animal Research, Gunma University School of Medicine, at the age of 3 weeks. Groups of 8 mice were housed in aluminium cages of 30 (D) x20 (W) x10 (H) cm with a wooden flake floor mat, and mice were allowed to free access to solid diet (MF: Oriental Yeast Co., Tokyo) and tap water throughout the experimental period, except at the times of drug administration and measurement of the ambulatory activity. The breeding room was artificially illuminated by fluorescent lamps on a 12 hr light-dark schedule (light on at 6 a.m. and light off at 6 p.m.), and the room tem perature was regulated to 23±2°C. Humidity was not controlled.
When the mice were 10 weeks of age and weighed 30-32 g, they were used for the drug test.
Apparatus and procedure: Sixteen tilting type round activity cages of 25 cm in diameter and 13 cm in height were used for the measurement of ambulatory activity in the mice. The principle of the device and the method for measurement of the activity were reported in detail by Hirabayashi et al. (23) . Briefly, a plexiglas round cage held at the center of the bottom was attached to 3 microswitches.
Each slight tilt of the cage according to the movement of a mouse was recorded through the microswitches. Thereby, only ambulation could be recorded.
A mouse was put into the activity cage, and the cumulative ambulatory activity counts during 10 min segments were measured for 30 and 90 min before and after the administration of scopolamine, respec tively.
All the experiments were carried out between 11 a.m.-3 p.m.
Drug and administration schedules: The drug used and the doses tested were sco polamine hydrobromide (Sigma Chemical Co., St. Louis, MO; 0.5, 2.0 and 8.0 mg/kg). The doses are expressed in terms of the salt form. The drug was dissolved in a physio logical saline vehicle and was administered subcutaneously.
Each administration volume was fixed to 1.0 ml per 100 g body weight.
Three-hundred and twenty mice were divided into 20 groups of 16 each. The schedules for repeated administration of scopolamine and/or the saline vehicle are shown in Table 1 . The ambulatory activities of the mice in Groups 1-9 were measured in the activity cages for a 90 min observation session after each administration of the corresponding dose of scopolamine for 6 times. The 1st-5th sessions were carried out at intervals of daily, 3-4 days or weekly. However, the 6th session was held 1 month after the 5th session. The mice in Groups 10-12 were also put into the activity cages, and their ambulatory activities were measured for 90 min after each administration. This experimental manipulation was carried out 5 times at intervals of 3-4 days. However, they were administered the saline vehicle instead of scopolamine during the 1st-4th session and scopolamine on the 5th session. The mice in Groups 13, 15 and 17 were administered the saline vehicle during the 1st-4th session, and scopolamine admin istered in the 5th session at intervals of 3-4 days. During the 1st-4th sessions, they were individually put into glass jars of 5.5 cm in Table 1 . Experimental schedules for repeated administration of scopolamine * One month after the 5th session . t: The physiological saline vehicle was administered during the 1 st-4th sessions, and scopolamine was administered on the 5th session. 1': A glass jar with a diameter of 5.5 cm and a height of 1 3 cm.
diameter and 13 cm in height, in which the ambulation of the mouse could be perfectly restricted (6, 9), for 90 min after each administration.
On the 5th session, the ambulatory activity of the mice in Groups 13, 15 and 17 were measured in the activity cages for 90 min after the administration of scopolamine. The mice in Groups 14, 16 and 18 were administered scopolamine at inter vals of 3-4 days for 5 times. However, during the 1st-4th sessions, they were individually put into the glass jars for 90 min after each administration.
On the 5th session, the ambulatory activity of the mice in Groups 14, 16 and 18 were measured in the activity cages for 90 min after the administration of scopolamine. The mice in Groups 19 and 20 were administered the saline vehicle at intervals of 3-4 days for 5 times. On the 1st 4th sessions, the former and latter mice were put into the activity cages and the glass jars, respectively; and on the 5th session, all of them were put into the activity cages for 90 min after each administration.
Statistical analysis: The experimental results obtained were analyzed by an analysis of variance (ANOVA). In cases of significant overall F-scores, individual differences of the activity counts were assessed statistically by Student's t-test. They were considered statistically significant when the P value was equal or less than 0.05. Figure 1 shows changes in mean overall ambulatory activity counts of the mice in Groups 1-9 after repeated administration of scopolamine at doses of 0.5, 2.0 and 8.0 mg/ kg s.c. at intervals of daily, 3-4 days and weekly for 5 sessions. The results on the 6th session, carried out 1 month after the 5th session, are also shown in this figure. AN OVA revealed significant dose-dependent, F(2, 675)=15.39, P<0.001; Interval dependent, F(2, 675)=9.18, P<0.001 ; and session-dependent, F (4, 675)=83.72, P< 0.001, changes in the mean ambulatory activity counts. The 1st administration of scopolamine induced a dose-dependent in crease in the ambulatory activity in the mice with a peak at 10-20 min after the adminis tration. However, the repeated administration of scopolamine at intervals of daily, 3-4 days and weekly produced a progressive decrease in the ambulation-increasing effect of sco polamine, i.e., induction of a tolerance. The development of tolerance tended to be more marked in the mice given scopolamine at intervals of daily than those given at intervals of 3-4 days and weekly. A slight attenuation of the tolerance was found 1 month after the cessation of the repeated administration, F(1, 135)=7.83, P<0.01. However, the ambulatory activity counts on the 6th session did not return to those on the 1st session. Figure 2 shows overall ambulatory activity counts on the 5th session of the mice in Groups 2, 5, 8 and those at 10-18 after the administration of scopolamine at 0.5, 2.0 and 8.0 mg/kg s.c. These mice had been pretreated with scopolamine or the saline vehicle either in the activity cage or in the glass jar during the 1st-4th sessions at intervals of 3-4 days as presented in Table 1 . The overall ambulatory activity counts of the mice in Group 19 on the 1st and 5th sessions were 27.5::L5.8 and 20.9±3.7, re spectively. The overall ambulatory activity count of the mice in Group 20 on the 5th session was 31.4±6.2. These data are excluded from the figure presentation. AN OVA revealed significant dose-dependent, F(2, 180)=7.25, P<0.001 ; treatment dependent (saline and drug), F(1, 180)= 12.68, P<0.0011 and situation-dependent (cage and jar), F(1, 180)=20.72, P<0.001, changes in the overall ambulatory activity counts. The mice pretreated with the saline vehicle for 4 times in both the activity cage and the glass jar did not exhibit any alteration in the susceptibility to the ambulation increasing effect of scopolamine. In contrast, the mice pretreated with scopolamine in the activity cage demonstrated a tolerance to the effect. However, even though scopola mine was administered for the same number of times, the mice pretreated with sco polamine 2.0 and 8.0 mg/kg in the glass jar demonstrated no marked alteration in the susceptibility to the ambulation-increasing effect of the drug. Pretreatment of scopola mine at 0.5 mg/kg in the glass jar induced an enhancement of the susceptibility to the drug. This result is consistent with those reported by many investigators (12-22, 24) that scopolamine increases the motor activity in mice and rats and facilitates operant responses in rats. We previously found that the facilitating effects of scopolamine on avoidance responses in rats were antagoniz ed by combined administration of a direct cholinergic agonist, pilocarpine, and an acetylcholinesterase inhibitor, physostigmine (14). Meyers et al. (18) also reported that scopolamine but not methylscopolamine induced an increase in the motor activity in rats. Therefore, the increase in the ambulatory activity observed after scopolamine is likely to be due to a central muscarinic-cholinergic blockade.
Results
The present experiment also demonstrates that a tolerance to the ambulation-increasing effect of scopolamine is induced in the mice which have been repeatedly administered the drug at 0.5-8.0 mg/kg s.c. at intervals of daily, 3-4 days and weekly in the activity cage which had space to allow the mouse to move freely. For the production of tolerance to the drug effects, pharmacological tolerance with an increase in the drug metabolism, alteration in the receptor sensitivity or alter ation in the neurotransmitter levels is generally considered to be involved. Rosic et al. (19) reported that a daily administration of sco polamine at 0.5 mg/kg s.c. for 21 days induced a tolerance to the ambulation increasing effect of the drug in the rats. They then concluded that an alteration in muscarinic-cholinergic receptor activities was induced by the repeated administration.
The development of tolerance observed in our experiment is more marked after the adminis tration of scopolamine at intervals of daily than 3-4 days and weekly. These results suggest that pharmacological tolerance is partially induced after the repeated adminis tration of scopolamine. However, as demonstrated in our experi ment, the tolerance to the ambulation increasing effect of scopolamine can be observed in the mice administered scopola mine at intervals of daily, 3-4 days and weekly and is maintained even after 1 month after the cessation of the repeated adminis tration. In addition, the mice which experi enced the scopolamine effect in the small jar do not exhibit a tolerance after 2.0 and 8.0 mg/kg. These results suggest that the tolerance to the ambulation-increasing effect of scopolamine after repeated administration may be only a behavioral tolerance and can be observed only in the mice exposed to the activity cage with a sufficient space for free movement during the presence of the drug effect. However, it is difficult to explain why a reverse tolerance is induced in the mice given scopolamine at 0.5 mg/kg in the glass jar.
On some points, the effects of scopolamine on animal behaviors are similar to those of amphetamines (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) 24 
